University Hospital of Child and Adolescent Psychiatry

Transkript

1 University Hospital of Child and Adolescent Psychiatry Curriculum Vitae Benno Graf Schimmelmann, MD Assistent Professor & Tenure Track University Hospital of Child & Adolescent Psychiatry University of Bern Bolligenstr. 111 CH-3000 Bern 60 Switzerland Tel.: Fax: Mail: Gelehrtenschule des Johanneums, Hamburg, Germany Medial school, at the Ludwig Maximilian University of Munich, Germany 1990 Research internship, at Medical College of Virginia, Richmond, USA Medical school, at the University Hospital Hamburg-Eppendorf, Germany 1993 Internship, at Cornell Medical Center, New York, USA 1996 Internship, at Yale Medical School, New Haven, USA 1998 Medical Licensure, Germany 1998 ECFMG Certificate (US American Medical Licensure Examination) 2000 Dissertation: Day treatment in child and adolescent psychiatry Residency, at University Hospital Hamburg-Eppendorf, Department of Child and adolescent Psychiatry and Psychotherapy, Hamburg, Germany Training in Child and Adolescent Psychotherapy (Curriculum Tiefenbrunn) Residency, at University Hospital Hamburg-Eppendorf, Department of Psychiatry; Implementation of an outpatient service for substance abusing adolescents and young adults and their families in cooperation with adult psychiatry (Prof. Dr. R. Thomasius) Residency, research fellow, Department of Child and Adolescent Psychiatry and Psychotherapy, Hamburg; Concept and implementation of Psychosis Early Detection and Intervention Centre (PEDIC) in cooperation with adult psychiatry (PD Dr. M. Lambert, Prof. Dr. D. Naber) Training in family therapy, Heidelberg curriculum (Prof. Cierpka) Consultant, research fellow, at the University of Duisburg-Essen, Department of Child and Adolescent Psychiatry (Prof. Dr. Hebebrand) Implementation of research outpatient service for ADHD First Episode Psychosis Outcome Study (FEPOS) in cooperation with Early Psychosis Prevention and Intervention Centre (EPPIC), Melbourne, Australia Assistant Professorship with tenure track, chief physician and head of Department of research at University Hospital of Child and Adolescent Psychiatry, University of Bern, Switzerland 08/2012- Professor of Child and Adolescent Psychiatry, University of Bern, Director of the University Hospital of Child and Adolescent Psychiatry and Psychotherapy 1

2 Main research interests Early onset psychosis, phenomenology, course of illness, treatment Early detection and intervention of psychosis Antipsychotic therapy Genetics of child and adolescent psychiatric disorders Journal Activities Junior Editor: European Child and Adolescent Psychiatry Associate Editor: Early Intervention in Psychiatry Editorial Board: Child and Adolescent Psychiatry and Mental Health Ad hoc referee American Journal of Medical Genetics (part B) Archives of General Psychiatry Attention deficit - and Hyperactivity Disorder (ADHD) Australian and New Zealand Journal of Psychiatry Behavioral Research and Therapy British Journal of Psychiatry Child and Adolescent Mental Health Early Intervention in Psychiatry European Child and Adolescent Psychiatry European Psychiatry Fortschritte der Neurologie und Psychiatrie International Journal of Neuropsychopharmacology Journal of Child and Adolescent Psychopharmacology Journal of Child Psychology and Psychiatry Journal of Clinical Psychiatry Journal of Psychiatric Research Molecular Psychiatry Neuropsychobiology Pharmacogenetics and Genomics Pharmacogenomics Pharmacopsychiatry Progress in Neuro-Psychopharmacology and Biological Psychiatry Psychopharmacology Psychiatry Research Psychiatry Research Neuroimaging Psychopathology Schizophrenia Research Schizophrenia Bulletin Zeitschrift für Ärztliche Qualitätssicherung Zeitschrift für Kinder- und Jugendpsychiatrie Zeitschrift für pädagogische Psychologie und Entwicklungspsychologie 2

3 Publications ( ) Originalia (* indicates Co-Firstauthorship) 2004 (1) Schimmelmann BG, Schacht M, Perro C & Lambert M (2004). Die initial dysphorische Reaktion auf die Ersteinnahme von Neuroleptika. Nervenarzt, 75(1):36-43 (2) Richter-Appelt H, Schimmelmann BG & Tiefensee J (2004). Fragebogen zu Erziehungseinstellungen und Erziehungspraktiken (FEPS). Psychotherapie, Psychosomatik und medizinische Psychologie, 54(1): (3) Schimmelmann BG, Paulus S, Schacht M, Tilgner C, Schulte-Markwort M & Lambert M (2005). Subjective distress related to side effects and subjective wellbeing in first admitted adolescents with early onset psychosis treated with atypical antipsychotics. Journal of Child and Adolescent Psychopharmacology, 15(2): (4) Schimmelmann BG, Moritz S, Karow A, Schäfer I, Bussopulos A, Golks D, Krausz M, Naber D & Lambert M (2005). Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics. International Journal of Psychiatry in Clinical Practice, 9(2):94-98 (5) Schimmelmann BG, Conus P, Edwards J, McGorry PD & Lambert M (2005). Diagnostic stability 18 months after treatment initiation for first-episode psychosis. Journal of Clinical Psychiatry, 66: (6) Lambert M, Conus P, Lubman DI, Wade D, Yuen HP, Moritz S, Naber D, McGorry P & Schimmelmann BG (2005). The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatrica Scandinavica, 112(2): (7) Lambert M, Conus P, Naber D, McGorry P & Schimmelmann BG (2005). Olanzapine in subjects with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone. International Journal of Psychiatry in Clinical Practice, 9(4): (8) Lambert M, Conus P, Schimmelmann BG, Eide P, Ward J, Yuen H, Schacht M, Edwards J, Naber D & McGorry PD (2005). Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study. Pharmacopsychiatry, 38(5): (9) Lambert M, Schimmelmann BG, Naber D, Schacht A, Karow A, Wagner T & Czekalla J (2006). Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. Journal of Clinical Psychiatry, 67(11): (10) Meng H, Schimmelmann BG, Mohler B, Lambert M, Branik E, Koch E, Karle M, Strauss M, Preuss U, Amsler F, Riedesser P, Resch F & Bürgin D (2006). Pretreatment social functioning predicts 1-year outcome in early onset psychosis. Acta Psychiatrica Scandinavica, 114(4):

4 (11) Schacht M, Richter-Appelt H, Schulte-Markwort M, Hebebrand J & Schimmelmann BG (2006). Eating Pattern Inventory for Children: a new selfrating questionnaire for preadolescents. Journal of Clinical Psychology, 62(10): (12) Schimmelmann BG, Conus P, Schacht M, McGorry P & Lambert M (2006). Predictors of Service Disengagement in First Admitted Adolescents with Psychosis. Journal of the American Academy of Child and Adolescent Psychiatry, 45(8): (13) Conus P, Cotton S, Schimmelmann BG, McGorry P & Lambert M (2007). The First-episode Psychosis Outcome Study (FEPOS): Pre-morbid and baseline characteristics of an epidemiological cohort of 661 first-episode psychosis patients. Early Intervention in Psychiatry, 1(2): (14) Friedel S*, Saar K*, Sauer S, Dempfle A, Walitza S, Renner T, Romanos M, Freitag C, Seitz C, Palmason H, Scherag A, Windemuth-Kieselbach C, Schimmelmann BG, Wewetzer C, Meyer J, Warnke A, Lesch KP, Reinhardt R, Herpertz-Dahlmann B, Linder M, Hinney A, Remschmidt H, Schäfer H, Konrad K, Hübner N & Hebebrand J (2007). Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Molecular Psychiatry, 12(10): (15) Karow A, Czekalla J, Dittmann RW, Schacht A, Wagner T, Lambert M, Schimmelmann BG & Naber D (2007). Association of subjective wellbeing, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. Journal of Clinical Psychiatry, 68(1):75-80 (16) Lambert M, Naber D, Eich FX, Schacht M, Linden M & Schimmelmann BG (2007). Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatrica Scandinavica, 115(2): (17) Schacht M, Richter-Appelt H & Schimmelmann BG (2007). Der Fragebogen zur Eltern-Kind-Beziehung für Kinder. Grundlagen und erste Ergebnisse. Psychotherapie, Psychosomatik, Medizinische Psychologie, 57(3-4): (18) Schimmelmann BG*, Conus P*, Cotton S, McGorry PD & Lambert M (2007). Pre-treatment, baseline, and outcome differences between early-onsetand adult-onset psychosis in an epidemiological cohort of 636 first-episode episode patients. Schizophrenia Research, 95:1-8 (19) Schimmelmann BG*, Friedel S*, Dempfle A, Warnke A, Lesch KP, Walitza S, Renner TJ, Romanos M, Herpertz-Dahlmann, Linder M, Schäfer H, Seitz C, Palmason H, Freitag C, Meyer J, Konrad K, Hinney A & Hebebrand J (2007). No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived-neurotrophic factor gene (BDNF) in ADHD. Journal of Neural Transmission, 114(4): (20) Schimmelmann BG, Mehler-Wex C, Lambert M, Schulze-zur-Wiesch C, Koch E, Flechtner H, Gierow G, Maier J, Meyer E & Schulte-Markwort M (2007). A prospective 12-week study of quetiapine in adolescents with schizophrenia spectrum disorders. Journal of Child Adolescent Psychopharmacology, 17(6):

5 2008 (21) Huber CG, Lambert M, Naber D, Schacht A, Hundemer HP, Wagner TT & Schimmelmann BG (2008). Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients. Schizophrenia Research, 100 (1-3): (22) Lambert M*, Huber CG*, Naber D, Schacht A, Wagner TT, Hundemer HP, Karow A & Schimmelmann BG (2008). Treatment of severe agitation with olanzapine in a cohort of 166 patients with schizophrenia, schizoaffective or bipolar I disorder. Pharmacopsychiatry, 41(5): (23) Lambert M, Naber D, Schacht A, Wagner TT, Hundemer HP, Karow A, Huber CG, Suarez D, Haro JM, Novick D, Dittmann RW & Schimmelmann BG (2008). Rates and predictors of remission and recovery during three years in 392 never-treated patients with schizophrenia. Acta Psychiatrica Scandinavica, 118(3): (24) Morley KI, Cotton SM, Conus P, Lambert M, Schimmelmann BG, McGorry PD & Foley DL (2008). Familial psychopathology in the First Episode Psychosis Outcome Study. Australian and New Zealand Journal of Psychiatry, 42(7): (25) Schimmelmann BG*, Huber CG*, Lambert M, Cotton S, McGorry PD & Conus P (2008). Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort. Journal of Psychiatric Research, 42(12): (26) Schützmann M, Richter-Appelt H, Schulte-Markwort M & Schimmelmann BG (2008). Associations Among the Perceived Parent Child Relationship, Eating Behavior, and Body Weight in Preadolescents: Results from a Community-based Sample. Journal of Pediatric Psychology, 33: (27) Wehmeier PM, Kluge M, Schacht A, Helsberg K, Schreiber W, Schimmelmann BG & Lambert M (2008). Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia. Journal of Psychiatric Research, 42(8): (28) Cotton SM, Lambert M, Schimmelmann BG, Foley DL, Morley KI, McGorry PD & Conus P (2009). Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis. Schizophrenia Research, 114(1-3):17-24 (29) Lambert M, Naber D, Karow A, Huber CG, Köhler J, Heymann J & Schimmelmann BG (2009). Subjective Wellbeing under quetiapine treatment: effect of diagnosis, mood state, and anxiety. Schizophrenia Research, 110(1-3):72-79 (30) Lambert M*, Schimmelmann BG*, Naber D, Eich FX, Schulz H, Huber CG & Karow A (2009). Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride. Pharmacopsychiatry, 42(6): (31) Lambert M*, Schimmelmann BG*, Schacht A, Karow A, Wagner T, Wehmeier PM, Huber CG, Hundemer HP, Dittmann RW & Naber D (2009). Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years. Schizophrenia Research, 107:

6 (32) Meng H*, Schimmelmann BG*, Koch E, Bailey B, Parzer P, Günter M, Mohler B, Kunz N, Schulte-Markwort M, Felder W, Zollinger R, Bürgin D & Resch F (2009). Basic symptoms in the general population and in psychotic and nonpsychotic psychiatric adolescents. Schizophrenia Research, 111(1-3):32-38 (33) Robinson J, Cotton S, Conus P, Schimmelmann BG, McGorry P & Lambert M (2009). Prevalence and predictors of suicide attempt in an incidence cohort of 661 young people with first-episode psychosis. Australian and New Zealand Journal of Psychiatry, 43: (34) Schimmelmann BG*, Friedel S*, Nguyen TT, Sauer S, Ganz Vogel CI, Konrad K, Wilhelm C, Sinzig J, Renner TJ, Romanos M, Palmason H, Dempfle A, Walitza S, Freitag C, Meyer J, Linder M, Schäfer H, Warnke A, Lesch KP, Herpertz-Dahlman B, Hinney A & Hebebrand J (2009). Exploring the genetic link between RLS and ADHD. Journal. of Psychiatric Research, 43: (35) Conus P, Cotton S, Schimmelmann BG, Berk M, Daglas R, McGorry PD & Lambert M (2010). Pretreatment and outcome correlates of past sexual and physical trauma in 118 bipolar I disorder patients with a first episode of psychotic mania. Bipolar Disorders, 12(3): (36) Conus P, Cotton S, Schimmelmann BG, McGorry PD, Lambert M (2010). Pretreatment and outcome correlates of sexual and physical trauma in an epidemiological cohort of first-episode psychosis patients. Schizophrenia Bulletin 36(6): (37) Conus P, Lambert M, Cotton SM, Bonsack C, McGorry PD & Schimmelmann BG (2010). Rate and predictors of service disengagement in an epidemiological first-episode psychosis cohort. Schizophrenia Research, 118 (1-3): (38) Lambert M, Bock T, Schöttle D, Golks D, Meister K, Rietschel L, Bussopulos A, Frieling M, Schödlbauer M, Burlon M, Huber C, Ohm G, Pakrasi M, Chirazi- Stark MS, Naber D & Schimmelmann BG (2010). Assertive Community Treatment (ACT) as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophreniaspectrum disorders treated with quetiapine immediate release (ACCESS trial). Journal of Clinical Psychiatry, 71(10): (39) Lambert M, Conus P, Cotton S, Robinson J, McGorry P & Schimmelmann BG (2010). Prevalence, predictors, and consequences of long-term refusal of antipsychotic treatment in first-episode psychosis. Journal of Clinical Psychopharmacology, 30(5): (40) Oades RD, Dauvermann M, Schimmelmann BG, Schwarz MJ & Myint AM (2010). Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism effects of medication. Behavioral and Brain Functions, 6:29 (41) Oades RD, Myint AM, Dauvermann M, Schimmelmann BG & Schwarz MJ (2010). Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention. Behavioral and Brain Functions, 6:32 (42) Robinson J, Harris M, Cotton S, Hughes A, Conus P, Lambert M, Schimmelmann BG & McGorry P (2010). Sudden death among young people 6

7 with first-episode psychosis: an 8-10 year follow-up study. Psychiatry Research, 177(3): (43) Christiansen H*, Kis B*, Hirsch O, Philipsen A, Henneck M, Panczuk A, Pietrowsky R, Hebebrand J & Schimmelmann BG (2011). German validation of the Conners Adult ADHD Rating Scales self-report (CAARS-S) I: Factor structure and normative data. European Psychiatry 26(2): (44) Lambert M*, Schimmelmann BG*, Schacht A, Suarez D, Haro JM, Novick D, Wagner T, Wehmeier PM, Huber CG, Hundemer HP, Dittmann RW, Naber D (2011) Differential 3-year effects of first- vs. second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models (MSMs). Journal of Clinical Psychopharmacology 31(2): (45) Schimmelmann BG, Conus P, Cotton SM, Kupferschmid S, Karow A, Schultze-Lutter F, McGorry PD, Lambert M (2011) Cannabis use disorder and age at onset of psychosis A study in first-episode patients. Schizophrenia Research 129(1):52-6 (46) Hinney A, Scherag A, Jarick I, Albayrak O, Pütter C, Pechlivanis S, Dauvermann M,, Beck S, Weber H, Scherag S, Nguyen TT, Volckmar AL, Knoll N, Schäfer H, Faraone SV, Neale BN, Franke B, Thapar A, GAIN consortium, Schreiber S, Jöckel KH, Wichmann HE, Freitag CM, Lempp T, Meyer J, Herpertz-Dahlmann B, Sinzig J, Lehmkuhl G, Renner TJ, Warnke A, Romanos M, Lesch KP, Reif A, Schimmelmann BG, & Hebebrand J (2011) Genome-wide association study in German patients with attention deficit hyperactivity disorder and population-based controls. American J Medical Genetics Part B (Neuropsychiatric Genetics) 156(8): (47) Cotton SM, Lambert M, Schimmelmann BG, Mackinnon A, Gleeson JFM, Berk M, Hides L, Chanen A, McGorry PD, C & Conus P (2012). Depressive symptoms in first episode schizophrenia spectrum disorder. Schizophrenia Research 134(1):20-6 (48) Karow A, Reimer J, König HH, Heider D, Bock T, Huber C, Schöttle D, Meister K, Rietschel L, Ohm G, Schulz H, Naber D, Schimmelmann BG, Lambert M (2012). Cost-effectiveness of 12-month therapeutic Assertive Community Treatment as part of Integrated Care vs. Standard Care in patients with schizophrenia treated with Quetiapine IR (ACCESS Trial). Journal of Clinical Psychiatry 73(3):e402-8 (49) Håvik B, Degenhardt FA, Johansson S, Fernandes CP, Hinney A, Scherag A, Lybæk H, Djurovic S, Christoforou A, Ersland KM, Giddaluru S, O'Donovan MC, Owen MJ, Craddock N, Mühleisen TW, Mattheisen M, Schimmelmann BG, Renner T, Warnke A, Herpertz-Dahlmann B, Sinzig J, Albayrak Ö, Rietschel M, Nöthen MM, Bramham CR, Werge T, Hebebrand J, Haavik J, Andreassen OA, Cichon S, Steen VM, Le Hellard S (2012) DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder. PLOS One 7(4):e35424 (50) Schultze-Lutter F*, Schimmelmann BG*, Klosterkötter J, Ruhrmann S (2012). Comparing the prodrome of schizophrenia-spectrum psychoses and affective disorders with and without psychotic features. Schizophrenia Research 138(2-3): (51) Christiansen H*, Kis B*, Hirsch O, Matthies S, Hebebrand J, Uekermann J, Abdel-Hamid M, Kraemer M, Wiltfang J, Graf E, Colla M, Sobanski E, Alm B, 7

8 Rösler M, Jacob C, Jans T, Huss M, Schimmelmann BG & Philipsen A (2012) German validation of the Conners Adult ADHD Rating Scales (CAARS) II: Reliability, validity, diagnostic sensitivity and specificity. European Psychiatry 27(5):321-8 (52) Schimmelmann BG, Conus P, Cotton SM, Kupferschmid S, McGorry PD & Lambert M (in press). Prevalence and Impact of Cannabis Use Disorders in Adolescents with Early Onset First Episode Psychosis. European Psychiatry, 27: In Press (53) Christiansen H*, Hirsch O*, Philipsen A, Oades R, Matthies S, Hebebrand J, Uekermann J, Abdel-Hamid M, Kraemer M, Wiltfang J, Graf E, Colla M, Sobanski E, Alm B, Rösler M, Jacob C, Jans T, Huss M, Schimmelmann BG & Kis B (in press) German validation of the Conners Adult ADHD Rating Scale self-report (CAARS-S): confirmation of factor structure in a large sample of subjects with ADHD. Journal of Attention Disorders DOI: / (54) Schöttle D*, Schimmelmann BG*, Conus P, Cotton SM, Michel C, McGorry, PD, Karow A, Naber D, Lambert M (in press) Differentiating schizoaffective and bipolar I disorder in first-episode psychotic mania. Schizophrenia Research Reviews /letters / case reports / editorial 2001 (1) Schimmelmann BG, Schulte-Markwort M & Richter R (2001). Die Tagesklinische Behandlung in der Kinder- und Jugendpsychiatrie. Zeitschrift für Kinder- und Jugendpsychiatrie, 29(3): (2) Lambert M, Schimmelmann BG, Haasen C & Naber D (2002). Subjektive Befindlichkeit unter Neuroleptika: Relevant für die Pharmakotherapie psychotischer Patienten? Psychopharmakotherapie, 2:53-59 (3) Schulte-Markwort M & Schimmelmann BG (2002). Aufmerksamkeitsdefizitund Hyperaktivitätsstörung (ADHS). Zeitschrift für Allgemeinmedizin, 78: (4) Lambert M, Schimmelmann BG, Karo A & Naber D (2003). Subjective wellbeing and Initial Dysphoric Reaction under Antipsychotic Drugs - concept, measurement and clinical relevance. Pharmacopsychiatry, 36(3 Suppl): (5) Schimmelmann BG, Meng H, Koch E, Karle M, Preuss U & Schulte- Markwort M (2003). Expressed Emotion im Verlauf kinder- und jugendpsychiatrischer Störungen. Fortschritte der Neurologie und Psychiatrie, 71: (6) Schimmelmann BG, Schulte-Markwort M & Resch F (2004). Kontroverse um Früherkennung psychotischer Störungen bei Jugendlichen. Forum Sozialpsychiatrie, 22:17-19 (7) Aderhold V, Lambert M, Bock T & Schimmelmann BG (2004). Psychosenbehandlung verbessern. Soziale Psychiatrie, 28 (1):12-14 (8) Duesterhus P, Schimmelmann BG, Witthugel O, Schulte-Markwort M (2004). Huntington disease: a case study of early onset presenting as depression. 8

9 Journal of the American Academy of Child and Adolescent Psychiatry, 43(10): (9) Schimmelmann BG, Friedel S, Dempfle A, Christiansen C, Hinney A & Hebebrand J (2006). Genetische Befunde bei der Aufmerksamkeitsdefizit- und Hyperaktivitätsstörung (ADHS). Zeitschrift für Kinder- und Jugendpsychiatrie, 34(6): (10) Friedel S, Schimmelmann BG; Hinney A & Hebebrand J (2007). Die genetischen Grundlagen der Aufmerksamkeitsdefizit- Hyperaktivitätsstörung (ADHD). Biologie unserer Zeit, 37(4): (11) Albayrak Ö, Friedel S, Schimmelmann BG, Hinney A & Hebebrand J (2008). Genetic aspects in Attention Deficit/Hyperactivity Disorder. Journal of Neural Transmission, 115(2): (12) Schimmelmann BG & Dittmann R (2009). Schizophrenie. Zeitschrift für Kinder- und Jugendpsychiatrie, 37(4): (13) Koch E, Schultze-Lutter F, Schimmelmann BG & Resch F (2010). On the importance and detection of prodromal symptoms from the perspective of child and adolescent psychiatry. Clinical Neuropsychiatry, 7(2):38-48 (14) Hebebrand J, Scherag A, Schimmelmann BG & Hinney A (2010). Child and adolescent psychiatry genetics. European Child and Adolescent Psychiatry, 19(3): (15) Uekermann J, Kraemer M, Abdel-Hamid M, Schimmelmann BG, Hebebrand J, Daum, I, Wiltfang J & Kis B (2010). Social cognition in attentiondeficit hyperactivity disorder (ADHD). Neuroscience and biobehavioral Reviews, 34(5): (16) Wermter AK, Laucht M, Schimmelmann BG, Banaschewski TT, Samga- Barke EJ, Rietschel M & Becker K (2010). From Nature versus nurture via nature and nurture, to gene x environment interaction in mental disorders. European Child & Adolescent Psychiatry, 19(3): (17) Lambert M, Karow A, Leucht S, Schimmelmann BG & Naber D (2010). Remission in schizophrenia: its validity, frequency, predictors and patients perspective 5 years after. Dialogues in Clinical Neuroscience, 12(3): (18) Resch F, Koch E, Schultze-Lutter F, Schimmelmann BG (2011). Schizophophrene Psychosen des Kindes- und Jugendalters. Psychiatrie und Psychotherapie up2date 5(2):85-98 (19) Schimmelmann BG, Michel C, Schaffner N & Schultze-Lutter F (2011). What percentage of people in the general population satisfies the current clinical at-risk criteria of psychosis? Schizophrenia Research, 125(1): (20) Schimmelmann BG (2011). Seclusion and restraints: a neglected area of research in child and adolescent psychiatry? European Child and Adolescent Psychiatry, 20(5): (21) Schultze-Lutter F, Schimmelmann BG, Ruhrmann S (2011). The near babylonian speech confusion in early detection of psychosis. Schizophrenia Bulletin, 37(4):

10 (22) Schultze-Lutter F, Koch E, Resch F & Schimmelmann BG (2011). Früherkennung von Psychosen bei Kindern und Adoleszenten. Sind entwicklungsbezogene Besonderheiten ausreichend berücksichtigt? Zeitschrift für Kinder- und Jugendpsychiatrie 39: (23) Schimmelmann BG (2011). Früherkennung von Psychosen: Risiken und Nutzen bei Kindern und Jugendlichen abwägen. Zeitschrift für Kinder- und Jugendpsychiatrie 39: (24) Schaffner N, Schimmelmann BG, Niedersteberg A, Schultze-Lutter F (2012). Versorgungswege von erstmanifesten psychotischen Patienten - eine Übersicht internationaler Studien. Fortschritte Neurologie Psychiatrie 80:72-78 In press (25) Simon A, Theodoridou A, Schimmelmann BG, Schneider R, Conus P (2012). The Swiss Early Psychosis Project SWEPP: a national network. Early Intervention in Psychiatry 6: (26) Ruhrmann S, Kolsterkötter J, Bodatscha M, Bechdolf A, Schimmelmann BG, Nikolaides A, Hilboll D, Schultze-Lutter F (2012) Pharmacological prevention and treatment in clinical at-risk states for psychosis. Current Pharmacocytical Design 18: (27) Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, Bechdolf A, Schimmelmann BG, Klosterkötter J (2012) Basic Symptoms and the prediction of first-episode psychosis. Current Pharmacocytical Design 18: (28) Schimmelmann BG, Schultze-Lutter F (2012) Early detection and intervention of psychosis in children and adolescents: urgent need for studies. European Child and Adolescent Psychiatry 21(5): (29) Fiori Nastro P, Schimmelmann BG, Gebhardt E, Monducci E, Resch F, Koch E, Schultze-Lutter F (2012) [Challanges in the early detection of psychosis in children and adolescents]. Riv Psichiatr 47(2): (30) Schimmelmann BG, Walger P, Schultze-Lutter F (in press) The significance of at-risk symptoms for psychosis in children and adolescents. Can J Psychiatry (31) Schultze-Lutter F, Schimmelmann BG, Ruhrmann S, Michel C (in press) A rose is a rose is a rose, but at-risk criteria differ. Psychopathology Books & book chapters / Manuale 1993 (1) Kasten E, Schimmelmann BG & Sabel B (1993). Medizinische Psychologie und Soziologie Edition Medizin, VCH, Weinheim & New York, Zweite bis sechste Auflage 1996, 1997, 1998, 1999, (2) Domagk G, Drechsel-Buchheidth A, Emmig CG, Schimmelmann BG, et al. GK1, Ex-amination autumn 1993, spring 1994 as well as GK1, Examen autumn Chapman and Hall, London, (3) Schulte-Markwort M & Schimmelmann BG (1999). Kinderängste. Midena- Verlag, Augsburg 10

11 2001 (4) Schulz E, Schulte-Markwort M & Schimmelmann BG. (2001) Antipsychotika in der Behandlung von Kindern und Jugendlichen mit Schizophrenen Psychosen. In: Naber D, Lambert M, Krausz M, Haasen C. Atypische Antipsychotika in der Behandlung Schizophrener Patienten. Uni-Med-Verlag, Bremen, 2. Auflage, pp (5) Englische Auflage des o.g. Buches: Naber D, Lambert M, Krausz M & Haasen C (2002). Atypical Antipsychotics in the Treatment of Schizophrenic Patients. Uni-Med-Verlag, Bremen, pp (6) Romer G & Schimmelmann BG (2004). Kinder als Täter : Diagnostisches und therapeutisches Vorgehen bei nicht strafmündigen sexuell aggressiven Jungen. In: Körner W, Lenz A (Hrsg.) Sexueller Missbrauch. Band 1: Grundlagen und Konzepte. Hogrefe, Göttingen, pp (7) Schulte-Markwort M & Schimmelmann BG. (2004) Differentiation between Borderline Personality Disorder and Schizophrenia. In: Bürgin D & Meng H. Childhood and Adolescence Psychosis. Karger, Basel, pp (8) Schimmelmann BG & Schulte-Markwort M. (2005) Quetiapin in der Behandlung von Kindern und Jugendlichen mit psychotischen Störungen. In: Möller HJ Das Quetiapin-Dossier. Schattauer, Stuttgart, pp (9) Hebebrand J, Reichwald K, Schimmelmann BG & Hinney A. (2008) Identifying Genes Underlying Child and Adolescent Psychiatric Disorders. In: Garralda ME & Flament M (Ed.) Working with Children and Adolescents: An Evidence-Based Approach to Risk and Resilience. Rowman & Littlefield Publishers Inc. Plymouth, pp (10) Christiansen H, Schmimmelmann BG, Oades RD & Hebebrand J (2009). Geman version of the Conners Adults ADHD Rating Scales (CAARS-S: L). North Tonawanda: Multi-Health Systems (11) Christiansen H, Schmimmelmann BG, Oades RD & Hebebrand J (2009). Geman version of the Conners Adults ADHD Rating Scales (CAARS-O: L). North Tonawanda: Multi-Health Systems (12) Schultze-Lutter F, Michel C, Ruhrmann S, Klosterkötter J, Schimmelmann BG (2011). Prediction and early detection of first-episode psychosis. In: Ristner M (Ed.) Handbook of Schizophrenia Spectrum Disorders, Volume II. Springer, Dordrecht, pp (13) Ruhrmann S, Schultze-Lutter F, Schimmelmann BG, Klosterkötter J (2011). Prevention and early intervention in at-risk states for developing psychosis. In: Ristner M (Ed.) Handbook of Schizophrenia Spectrum Disorders, Volume III. Springer, Dordrecht, pp In press (14) Schimmelmann BG. Giving medication: On the interaction of psychotherapy and psychopharmacotherapy. In: Resch F, Schulte-Markwort M, Sannwald S (in press) Skills in child- and adolescent psychotherapy. Vandenhoeck & Ruprecht; Göttingen. (15) Schimmelmann BG, Resch F. Psychosen im Kindes- und Jugendalter. In: Hoffmann G et al.: Pädiatrie Grundlagen und Praxis, 4. Auflage. Springer 11

12 Selected abstracts 2006 (4) Conus P, Cotton S, Schimmelmann BG, McGorry PD & Lambert M (2006). The first episode psychosis outcome study (FEPOS): Pre-morbid and baseline characteristics of 740 first episode psychosis patients treated in EEPIC between 1998 and XIIIth Biennial winter workshop on schizophrenia research, Schizophrenia Research, 81(3 Suppl):308 (5) Huber C, Schimmelmann BG, Conus P, Naber D, McGorry P & Lambert M (2006). Association of duration of untreated psychosis (DUP) and outcome in an epidemiological sample of 668 patients with first-episode psychosis. XIIIth Biennial Winter workshop on schizophrenia research, Der Nervenarzt, 77(3 Suppl):S135 (6) Lambert M, Schimmelmann BG, Naber D, Schacht A & Czekalla J (2006). Long-term improvement of subjective well-being of schizophrenia outpatients correlates with early effective treatment and social functioning. The Journal of the European College of Neuropsychopharmacology, 16(4 Suppl):395 (7) Naber D, Schimmelmann BG, Czekalla J, Siemer A, Wagner T & Lambert M (2006). Prediction of short-term complete remission as a combination of symptomatic-, functional-, and subjective well-being remission in 2960 patients with schizophrenia. XIIIth Biennial Winter workshop on schizophrenia research, Schizophrenia Research, 81(3 Suppl):308 (8) Schimmelmann BG, Conus P, McGorry P & Lambert M (2006). Service Disengagement in First Admitted Adolescents with Psychosis. 29. DGKJP Kongress, Heidelberg. Journal of the American Academy of Child & Adolescent Psychiatry, 45(8): (9) Schimmelmann BG, Conus P, Schacht M, McGorry PD & Lambert M (2006). Predictors of non-adherence with treatment in first admitted adolescents with psychosis. XIIIth Biennial Winter workshop on schizophrenia research, Schizophrenia Research, 81(3 Suppl): (10) Christiansen H, Kalla H, Dembski N, Schimmelmann BG & Schoelmerich A (2007). Differences between verbal and performance IQ in the Hamburg- Wechsler Intelligence Scale for children (WISC) a typical pattern for children with ADHD? International Danube Symposium for Neurological Sciences and Continuing Education and 1st International Congress on ADHD, from childhood to adult disease. Journal of Neural Transmission, 114(17):LXXI (11) Friedel S, Saar K, S. Sauer, A. Dempfle, S. Walitza, T. Renner, M. Romanos, C. Freitag, C. Seitz, H. Palmason, A. Scherag, C. Windemuth- Kieselbach, Schimmelmann BG et al. (2007). Association and linkage of allelic variants of the dopamine transporter gene in ADHD. International Danube Symposium for Neurological Sciences and Continuing Education and 1st International Congress on ADHD, from childhood to adult disease. Journal of Neural Transmission, 114(17):LXXXII (12) Huber CG, Lambert M, Naber D, Schacht A, Hundemer HP, Wagner TT, Karow A & Schimmelmann BG (2007). Validierung der Clinical Global Impression Skala für Aggression (CGI-A) in einer Kohorte von 558 psychiatrischen Patienten. DGPPN 2007, Berlin. Der Nervenarzt, 78(2 Suppl):95 12